Marco Weibel

Marco Weibel

Active Investor

Chief Financial Officer

Switzerland

Marco Weibel, Chief Financial Officer is an active investor based in Switzerland. This profile covers what Marco Weibel backs, at which stage, and how founders can reach out in 2026.

Investor type
VCPE
Stages
SeedSeries ASeries BLate Stage Venture
Invests in
FintechHealthcare & BiotechBiotech & PharmaIoT & Connected DevicesGaming & EntertainmentMedia & ContentTravel & Hospitality
Location
Switzerland
Typical check
$2M
Past investments
34

Notable investments

Black Diamond TherapeuticsBlueprint MedicinesTRACON PharmaceuticalsJounce TherapeuticsPeloton TherapeuticsArvinasCullinan OncologySilverback TherapeuticsSunesis PharmaceuticalsMolecularMDMOMA TherapeuticsScorpion Therapeutics

How to reach Marco Weibel

Angels and operators like Marco Weibel reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Marco Weibel invest in?

Marco Weibel invests in Fintech, Healthcare & Biotech, Biotech & Pharma and IoT & Connected Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Marco Weibel?

Unlock Marco Weibel's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.

Similar investors

Browse all investorsIs this you? Email team@roundfunded.com to update or remove your profile.